| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/09/2023 | HOLOGIC INC | HOLX | Grant | Common Stock | 1.5k | $0.00 | $0 | | 03/09/2023 |
| 03/09/2023 | HOLOGIC INC | HOLX | Grant | Non-qualified Stock Option (Right to Buy) | 4.2k | $78.49 | $330.4k | | 03/09/2023 |
| 03/10/2022 | HOLOGIC INC | HOLX | Grant | Non-qualified Stock Option (Right to Buy) | 5.3k | $70.28 | $372k | | 03/10/2022 |
| 03/10/2022 | HOLOGIC INC | HOLX | Grant | Common Stock | 1.6k | $0.00 | $0 | | 03/10/2022 |
| 07/21/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Disposition | Common Stock, par value $.0001 per share | 580.8k | $0.00 | $0 | | 07/21/2021 |
| 07/21/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Disposition | Option to Purchase Common Stock | 56.8k | $118.83 | $6.7M | | 07/21/2021 |
| 07/14/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 120.9k | $0.00 | $0 | | 07/14/2021 |
| 07/14/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 119.8k | $0.00 | $0 | | 07/14/2021 |
| 03/29/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 2.3k | $154.03 | $359.2k | | 03/29/2021 |
| 03/11/2021 | HOLOGIC INC | HOLX | Grant | Common Stock | 1.5k | $0.00 | $0 | | 03/11/2021 |
| 03/11/2021 | HOLOGIC INC | HOLX | Grant | Non-qualified Stock Option (Right to Buy) | 5.1k | $71.03 | $359.1k | | 03/11/2021 |
| 02/28/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 83.7k | $0.00 | $0 | | 02/28/2021 |
| 12/16/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 162.7k | $0.00 | $0 | | 12/16/2020 |
| 12/16/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 72.5k | $157.96 | $11.5M | | 12/16/2020 |
| 12/16/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 13.1k | $157.96 | $2.1M | | 12/16/2020 |
| 03/30/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 3.2k | $85.43 | $273.5k | | 03/30/2020 |
| 03/05/2020 | HOLOGIC INC | HOLX | Grant | Non-qualified Stock Option (Right to Buy) | 7.3k | $47.36 | $346.8k | | 03/05/2020 |
| 03/05/2020 | HOLOGIC INC | HOLX | Grant | Common Stock | 2.2k | $0.00 | $0 | | 03/05/2020 |
| 03/02/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 8.4k | $90.54 | $761.1k | | 02/28/2020 |
| 02/28/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 44.2k | $0.00 | $0 | | 02/28/2020 |
| 02/07/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 12.8k | $102.97 | $1.3M | | 02/07/2020 |
| 03/07/2019 | HOLOGIC INC | HOLX | Grant | Common Stock | 2.1k | $0.00 | $0 | | 03/07/2019 |
| 03/07/2019 | HOLOGIC INC | HOLX | Grant | Non-qualified Stock Option (Right to Buy) | 6.5k | $46.81 | $305.3k | | 03/07/2019 |
| 02/28/2019 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 4k | $132.92 | $537.4k | | 02/28/2019 |
| 02/28/2019 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 37.2k | $0.00 | $0 | | 02/28/2019 |
| 02/07/2019 | ALEXION PHARMACEUTICALS, INC. | ALXN | Payment of Exercise | Common Stock, par value $.0001 per share | 13k | $119.57 | $1.6M | | 02/07/2019 |
| 12/31/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 3.2k | $95.85 | $310.9k | | 12/31/2018 |
| 11/21/2018 | HOLOGIC INC | HOLX | Grant | Common Stock | 659 | $0.00 | $0 | | 11/21/2018 |
| 11/21/2018 | HOLOGIC INC | HOLX | Grant | Non-qualified Stock Option (Right to Buy) | 2k | $41.54 | $83.6k | | 11/21/2018 |
| 02/28/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 35.8k | $0.00 | $0 | | 02/28/2018 |
| 02/08/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 13.2k | $116.31 | $1.5M | | 02/06/2018 |
| 02/06/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 95.3k | $0.00 | $0 | | 02/06/2018 |
| 01/02/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 2.6k | $121.63 | $310.5k | | 01/02/2018 |
| 06/03/2016 | Baxalta Inc | BXLT | Grant | | 16.4k | $0.00 | $0 | | 06/03/2016 |
| 06/03/2016 | Baxalta Inc | BXLT | Disposition | | 435.1k | $0.00 | $0 | | 06/03/2016 |
|